Scientists Turn Brain Cells Into Alzheimer's Plaque Cleaners

Scientists just turned one of the most common cells in your brain into a powerful weapon against Alzheimer's disease.

Researchers at Washington University School of Medicine in St. Louis have created a one-shot therapy that transforms ordinary brain cells called astrocytes into plaque-clearing machines. Unlike current Alzheimer's drugs that require monthly infusions, this experimental treatment needs just a single injection.

The results in mice were stunning. When given before plaques formed, the therapy completely prevented them from appearing. In older mice with brains already packed with harmful amyloid plaques, a single treatment reduced those plaques by about half within three months.

The approach borrows from cancer treatment. Scientists used the same CAR technology that helps modified immune cells hunt down tumors. But instead of engineering immune cells, they gave astrocytes (the brain's most abundant support cells) a special homing device to find and destroy the sticky proteins that build up in Alzheimer's brains.

Lead researcher Yun Chen introduced a gene into astrocytes using a harmless virus. Once the gene was active, the cells grew special receptors on their surface that let them grab onto amyloid beta proteins and swallow them up.

"This study marks the first successful attempt at engineering astrocytes to specifically target and remove amyloid beta plaques in the brains of mice with Alzheimer's disease," said senior author Dr. Marco Colonna.

Normally, immune cells called microglia handle brain cleanup duty. But during Alzheimer's, they become overwhelmed and can't keep up with the growing mess of harmful proteins. By recruiting the brain's most plentiful cells to help, scientists created millions of additional cleaners.

Why This Inspires

Current Alzheimer's drugs can slow the disease by about 10 months, giving patients precious extra time with independence. But they require large doses through IV infusions every month or two. This new approach could potentially work better while requiring just one treatment.

The therapy worked in two scenarios. Young mice that got the treatment before plaques appeared had completely clear brains by six months old, when untreated mice would normally be packed with plaques. Older mice that already had significant buildup saw their plaque levels drop by half.

The scientists have already filed a patent for their engineering method. More research is needed to optimize the approach and watch for side effects, but the door is now open for a fundamentally different way to fight neurodegenerative diseases.

These engineered astrocytes could one day help millions of families facing Alzheimer's keep their loved ones healthy and independent for years longer.